-
Tytuł:
-
Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD4+ T Cells in Patients With Rheumatoid Arthritis.
-
Autorzy:
-
Rims, Cliff
Uchtenhagen, Hannes
Kaplan, Mariana J.
Carmona‐Rivera, Carmelo
Carlucci, Philip
Mikecz, Katalin
Markovics, Adrienn
Carlin, Jeffrey
Buckner, Jane H.
James, Eddie A.
-
Temat:
-
CELL proliferation
ALGORITHMS
BIOLOGICAL assay
DRUG delivery systems
GENETIC techniques
IMMUNOGENETICS
PROTEOLYTIC enzymes
RHEUMATOID arthritis
STAINS & staining (Microscopy)
T cells
HLA-B27 antigen
CD4 antigen
-
Źródło:
-
Arthritis & Rheumatology; Apr2019, Vol. 71 Issue 4, p518-528, 11p
-
Objective: Recognition of citrullinated antigens such as vimentin, fibrinogen, and α‐enolase is associated with rheumatoid arthritis (RA). Emerging data suggest that the matrix protein aggrecan is also recognized as a citrullinated antigen. This study was undertaken to directly visualize Cit‐aggrecan–specific T cells and characterize them in patients with RA. Methods: Citrullinated aggrecan peptides with likely DRB1*04:01 binding motifs were predicted using a previously published scanning algorithm. Peptides with detectable binding were assessed for immunogenicity by HLA tetramer staining, followed by single cell cloning. Selectivity for citrullinated peptide was assessed by tetramer staining and proliferation assays. Ex vivo tetramer staining was then performed to assess frequencies of aggrecan‐specific T cells in peripheral blood. Finally, disease association was assessed by comparing T cell frequencies in RA patients and controls and correlating aggrecan‐specific T cells with levels of aggrecan‐specific antibodies. Results: We identified 6 immunogenic peptides, 2 of which were the predominant T cell targets in peripheral blood. These 2 epitopes were citrullinated at HLA binding residues and shared homologous sequences. RA patients had significantly higher frequencies of Cit‐aggrecan–specific T cells than healthy subjects. Furthermore, T cell frequencies were significantly correlated with antibodies against citrullinated aggrecan. Conclusion: Our findings indicate that T cells that recognize citrullinated aggrecan are present in patients with RA and correlate with antibodies that target this same antigen. Consequently, aggrecan‐specific T cells and antibodies are potentially relevant markers that could be used to monitor patients with RA or at‐risk subjects. [ABSTRACT FROM AUTHOR]
Copyright of Arthritis & Rheumatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)